AccessFYI - Resource Center

SiteStore

Store |

Wish List |

Cart |

Print |

Email This Page |

Report a Dead Link

Resource Center

	Press Releases
	White Papers
	Reports
	Yellow Pages
	Podcasts
	Videos
	Web Seminars
	Conferences
	Workshops
	eLearning
	Publications
		Trade Publications
		Medical Journals
		Health Magazines
		Books
		Newsletters

Blogs

Chat

Job Center

Health Categories

Press Releases

If you would like your company’s press releases represented on AccessFYI, you can quickly and easily submit them into our searchable database using the “Upload Content” button.
You must be a member and be logged in to have this capability.

Contact Dan Limbach if you have questions or comments.

From Members PhRMA News From the Wire

Sort By Reverse Sort

FDA Submission of Isosulfan Blue Injection ANDA Publisher: Synerx Pharma, LLC Category: Drug Development, Gov't/Regulatory Date: 12/16/2008		View Detail User Ratings: 0
	NEWTOWN, Pa.--(BUSINESS WIRE)--Synerx Pharma, LLC announces the submission to the FDA of Isosulfan Blue Injection (generic equivalent to Lymphazurin™, Covidien (formerly US Surgical)). This ANDA submission is the culmination of a four year joint effort by Synerx Pharma, LLC and its exclusive raw material supplier Apicore, LLC. According to...

OSI Pharmaceuticals Announces the Appointment of Mr. Pierre Legault as Executive Vice President and Chief Financial Officer Publisher: OSI Pharmaceuticals, Inc. Category: Drug Development, Operations Date: 12/16/2008		View Detail User Ratings: 0
	MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today the appointment of Mr. Pierre Legault as Executive Vice President, Chief Financial Officer and Treasurer. Mr. Legault has over 16 years of senior management experience in the pharmaceutical industry including several senior positions at Sanofi-Aventis and...

Hospitals, Healthcare Providers to Save with Premier’s New Surgical Endoscopy and Video Equipment Agreements Publisher: Premier Purchasing Partners Category: Operations, Managed Markets Date: 12/16/2008		View Detail User Ratings: 0
	CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier Purchasing Partners, LP, today announced new agreements for surgical endoscopy and video equipment have been awarded to ConMed of Utica, N.Y. and Olympus America Inc. of Center Valley, Pa. The category has been expanded to encompass the range of products currently found under the GI Products and...

Obagi Medical Products Expands Partnership with Japan-Based Rohto Pharmaceutical Co., Ltd. Publisher: Obagi Medical Products, Inc. Category: Drug Development, Operations, Manufacturing, Strategy Date: 12/16/2008		View Detail User Ratings: 0
	LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced an expansion of its relationship to Rohto Pharmaceutical Co., Ltd., (TYO:4527) a leading brand manufacturer of over-the-counter products, and Obagi’s leading marketing and...

CellPort Technologies™ from Absorption Systems enable AstraZeneca R&D to Investigate Drug Interactions Publisher: Absorption Systems, LP Category: Drug Development, Operations Date: 12/16/2008		View Detail User Ratings: 0
	EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems, LP, today announced that results of a recent investigation of interactions between drugs using Absorption Systems’ CellPort Technologies™ were presented by AstraZeneca at the International Society for the Study of Xenobiotics (ISSX) Meeting, which was held recently in San Diego. The results...

Clinical Data, Inc. Reaffirms Support for Current Regulation of Laboratory-Developed Tests Publisher: Clinical Data, Inc. Category: Drug Discovery, Drug Development Date: 12/16/2008		View Detail User Ratings: 0
	NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) announced today that it intends to oppose a Citizen Petition filed with the U.S. Food and Drug Administration (FDA) by Genentech, Inc. (NASDAQ: DNA), which requested that the agency regulate more stringently all laboratory-developed tests (LDTs) that are used to guide...

BioSante Pharmaceuticals Secures Committed Equity Financing Facility Publisher: BioSante Pharmaceuticals, Inc. Category: Drug Development, Strategy Date: 12/16/2008		View Detail User Ratings: 0
	LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited in which Kingsbridge has committed to provide up to $25 million in cash during the next two years, at BioSante’s discretion, through the...

HealthMedia Named “Company of the Year” and Receives Several More Distinguished Awards Publisher: HealthMedia, Inc. Category: Marketing Date: 12/16/2008		View Detail User Ratings: 0
	ANN ARBOR, MICH. – December 16, 2008 – HealthMedia, Inc., the pioneer in applying advanced technology to emulate a health coaching session via the web – without the coach – for wellness, behavioral health, disease management, aging well, and medication adherence, continues to be acknowledged as a leader in business and healthcare innovation...

Millipore Corporation and Guava Technologies to Award Instrumentation to Advance Cell Biology Research Publisher: Millipore Corporation and Guava Technologies Category: Drug Development, Operations Date: 12/15/2008		View Detail User Ratings: 0
	BILLERICA, Mass. & HAYWARD, Calif.--(BUSINESS WIRE)--Millipore Corporation and Guava Technologies announced today they will jointly award a Guava® flow cytometer instrument valued at over $100,000 USD to a scientist whose innovative research proposal will advance the understanding of cell biology.

Kamada Completes Enrollment in its Phase II Bronchiectasis Trial with Inhaled AAT Publisher: Kamada Category: Drug Development, Clinical Trials, Marketing, Operations Date: 12/15/2008		View Detail User Ratings: 0
	NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, production and marketing of specialty life-saving biotherapeutics, announced today that it has completed patient enrollment in its Phase II clinical trial evaluating treatment of bronchiectasis patients with inhaled Alpha-1...

INVIRION Diagnostics Launches Successful Hybrid Instrument at EUROGIN 2008 Publisher: INVIRION Diagnostics, LLC Category: Operations, Strategy Date: 12/15/2008		View Detail User Ratings: 0
	OAK BROOK, Ill.--(BUSINESS WIRE)--INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and...

FDA Approves Genzyme’s Mozobil Publisher: Genzyme Corporation Category: Drug Development, Gov't/Regulatory Date: 12/15/2008		View Detail User Ratings: 0
	CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that the U.S. Food and Drug Administration has granted marketing approval for Mozobil™ (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream...

Hawaii Biotech Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine Publisher: Hawaii Biotech, Inc. Category: Drug Development, Clinical Trials Date: 12/15/2008		View Detail User Ratings: 0
	HONOLULU--(BUSINESS WIRE)--Hawaii Biotech, Inc. announced today that it has completed dosing of healthy subjects in a multiple dose safety study of its West Nile Virus vaccine. President and CEO Elliot Parks, Ph.D., indicated that preliminary safety results and immunologic data from the 24 subjects treated with three doses of the vaccine will...

Neuroptix Corp. Names Gerald D. Cagle, Ph.D., as Chief Operating Officer Publisher: Neuroptix Corporation Category: Drug Development, Clinical Trials, Operations Date: 12/15/2008		View Detail User Ratings: 0
	ACTON, Mass.--(BUSINESS WIRE)--Neuroptix Corporation, a leading pioneer in the early detection of Alzheimer’s Disease through a non-invasive eye test, today announced that it has named Gerald D. Cagle, Ph.D., as the company's first Chief Operating Officer.

Piedmont Medical Group (PMG) Partners with Icon Clinical Research Publisher: Piedmont Medical Group and ICON Clinical Research Category: Clinical Trials, Strategy Date: 12/15/2008		View Detail User Ratings: 0
	WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Piedmont Medical Group (PMG), a leader in the clinical research industry with an experienced Integrated Site Network (ISN) of clinical research facilities, and ICON Clinical Research, a division of ICON plc, today announced an agreement that formalizes the working relationship between the two companies....

Page 1 of 7 |< << Prev 1 2 3 4 5 6 7 Next >> >|